James D Cooper1, Kenneth J Smith, A Kim Ritchey. 1. Division of Hematology/Oncology/BMT, Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15224, USA. james.cooper@chp.edu
Abstract
BACKGROUND: The American Society of Pediatric Otolaryngology recommends pre-operative coagulation testing only when indicated by history or physical exam. Nevertheless, many surgeons test all children scheduled for tonsillectomy and/or adenoidectomy (T&A). Studies of pre-operative screening have had conflicting results. A decision analysis model was constructed to address the costs and health outcome states of pre-operative screening strategies in children. PROCEDURE: A 14-day Markov model evaluated three strategies: (1) test all children for coagulation disorders; (2) test only those children with a pertinent history; and (3) perform no pre-operative testing. A literature search and a review of national databases estimated probabilities, costs, and utility data. Parameters then were varied widely in sensitivity analyses. Using a societal perspective and a cycle length of 1 day, we compared the strategies based on total costs and quality-adjusted life years (QALYs). RESULTS: Total costs for the strategies were $3,200 for testing all children, $3,083 for testing only those with a history finding, and $3,077 for not testing. Total utilities were 0.02579, 0.02654, and 0.02659 QALYs, respectively. Cost-effectiveness ratios were most sensitive to variation in the cost of post-operative care and the probability of post-operative bleeding. The strategy of not testing was dominant in all sensitivity analyses. CONCLUSIONS: Our results demonstrate that not performing preoperative testing is the most cost-effective strategy. This was persistent in sensitivity analyses, indicating that the model was robust. These data may be helpful to institutions and organizations to formulate policies regarding pre-operative coagulation for children without previous diagnoses of bleeding disorders.
BACKGROUND: The American Society of Pediatric Otolaryngology recommends pre-operative coagulation testing only when indicated by history or physical exam. Nevertheless, many surgeons test all children scheduled for tonsillectomy and/or adenoidectomy (T&A). Studies of pre-operative screening have had conflicting results. A decision analysis model was constructed to address the costs and health outcome states of pre-operative screening strategies in children. PROCEDURE: A 14-day Markov model evaluated three strategies: (1) test all children for coagulation disorders; (2) test only those children with a pertinent history; and (3) perform no pre-operative testing. A literature search and a review of national databases estimated probabilities, costs, and utility data. Parameters then were varied widely in sensitivity analyses. Using a societal perspective and a cycle length of 1 day, we compared the strategies based on total costs and quality-adjusted life years (QALYs). RESULTS: Total costs for the strategies were $3,200 for testing all children, $3,083 for testing only those with a history finding, and $3,077 for not testing. Total utilities were 0.02579, 0.02654, and 0.02659 QALYs, respectively. Cost-effectiveness ratios were most sensitive to variation in the cost of post-operative care and the probability of post-operative bleeding. The strategy of not testing was dominant in all sensitivity analyses. CONCLUSIONS: Our results demonstrate that not performing preoperative testing is the most cost-effective strategy. This was persistent in sensitivity analyses, indicating that the model was robust. These data may be helpful to institutions and organizations to formulate policies regarding pre-operative coagulation for children without previous diagnoses of bleeding disorders.
Authors: Giuseppe Tagariello; Paolo Radossi; Roberta Salviato; Milena Zardo; Lucia De Valentin; Marco Basso; Giancarlo Castaman Journal: Blood Transfus Date: 2016-07-22 Impact factor: 3.443
Authors: Joan Cox Gill; Stephen F Conley; Victoria P Johnson; Pamela A Christopherson; Sandra L Haberichter; Christina D Diaz; Tatyana C Strong; Jian Zhang; Pippa Simpson; Thomas C Abshire; Robert R Montgomery; Veronica H Flood Journal: Blood Adv Date: 2020-01-14
Authors: Stefanie Digiandomenico; Stephen F Conley; Victoria P Johnson; Pamela A Christopherson; Sandra L Haberichter; Jian Zhang; Pippa Simpson; Thomas C Abshire; Robert R Montgomery; Veronica H Flood Journal: Pediatr Blood Cancer Date: 2021-10-04 Impact factor: 3.167
Authors: Sarah H O'Brien; Sherif M Badawy; Seth J Rotz; Mona D Shah; Julie Makarski; Rachel S Bercovitz; Mary-Jane S Hogan; Lori Luchtman-Jones; Julie A Panepinto; Ginna M Priola; Char M Witmer; Julie A Wolfson; Marianne Yee; Lisa K Hicks Journal: Blood Adv Date: 2022-01-25